 |
Biogen Idec is the third largest biopharmaceutical company in the world, involved with the discovery, development, manufacturing and commercialization of innovative therapies. Its products address diseases such as multiple sclerosis and the multiple challenges of oncology.
www.biogenidec.com
|
|
 |
Ipsen is an international specialty pharmaceutical group specializing in targeted therapeutic areas, mainly oncology, endocrinology and neuromuscular disorders.
It has R&D centers in Boston, London, Paris and Barcelona.
www.ipsen.com
|
|
 |
Shire is a global specialty biopharmaceutical company serving the specialist physician. It focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. Shire acquired Transkarvotic Therapies Inc (TKT) in 2005 and the new company is called Shire Human Genetic Therapies.
www.shire.com
|
|
 |
Cephalon is an international biopharmaceutical company dedicated to the discovery, development and marketing of innovative products in four core therapeutic areas: central nervous system, pain, oncology and addiction. www.cephalon.com
|
|
 |
Astellas is a global pharmaceutical company based in Japan. Its aim is to contribute to better health for everyone by developing innovative and useful pharmaceuticals and delivering them to patients around the world. www.astellas.com
|
|
 |
Cubist Pharmaceuticals is a biopharmaceutical company focusing on the research, development and commercialization of pharmaceutical products directed towards the acute care environment.
www.cubist.com
|
|
 |
MGI Pharma is a USA-based biopharmaceutical company focused in oncology and acute care that acquires, researches, develops and commercializes proprietary products. It collaborates with partners to reach international markets.
www.mgipharma.com
|
|
 |
The Medicines Company, based in the USA, delivers innovative, cost-effective acute care products in the worldwide hospital marketplace. It markets Angiomax(R) (bivalirudin) for use in patients undergoing coronary angioplasty. www.themedicinescompany.com
|
|
 |
Tercica is a biopharmaceutical company committed to improving endocrine health by partnering with the endocrine community to develop and commercialize new therapeutics for short stature and other metabolic disorders.
www.tercica.com
|
|
 |
Biomarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. A special area of achievement is in treating mucopolysaccharidosis VI (MPS VI) and mucopolysaccharidosis I (MPS I).
www.biomarinpharm.com
|
|
 |
Avanir Pharmaceuticals is focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases. These products treat central nervous system disorders, inflammation and infectious disease.
www.avanir.com
|
|
 |
Nycomed is a Danish pharmaceutical company serving hospitals, specialists and general practitioners, as well as OTC medicines in selected markets. Its fields include cardiology, gastroenterology, osteoporosis, respiratory, pain and tissue management.
www.nycomed.com
|
|
